Peptide inhibitors of botulinum neurotoxin by mRNA display

Biochemical and Biophysical Research Communications

Volumn 335, Issue 4, 2005, Pages 1247-1253

  Yiadom, Kwabena P A B ^a,b   Muhie, Seid ^a   Yang, David C H ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b Office of the Secretary of Defense   (United States)

Author keywords

Biotin; Botulinum; Expression and purification; Medium throughput assay; mRNA display; Peptide inhibitor; Protease; Synthetic cDNA; Toxin; Transcription; Translation; Ubiquitin

Indexed keywords

BIOTIN; BOTULINUM TOXIN; COMPLEMENTARY DNA; HYBRID PROTEIN; MESSENGER RNA; METALLOPROTEINASE; PEPTIDE; PEPTIDE LIBRARY; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UBIQUITIN;

ARTICLE; DNA PURIFICATION; ESCHERICHIA COLI; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; BINDING SITES; BOTULINUM TOXIN TYPE A; COMPUTER SIMULATION; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; RNA, MESSENGER;

ESCHERICHIA COLI;

EID: 24044537606     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.196     Document Type: Article

References (31)

1. L.L. Simpson Identification of the major steps in botulinum toxin action Annu. Rev. Pharmacol. Toxicol. 44 2004 167 193
2. Y. Humeau, F. Doussau, N.J. Grant, and B. Poulain How botulinum and tetanus neurotoxins block neurotransmitter release Biochimie 82 2000 427 446
3. G. Schiavo, and F.G. van der Goot The bacterial toxin toolkit Nat. Rev. Mol. Cell Biol. 2 2001 530 537
4. C. Montecucco, and G. Schiavo Structure and function of tetanus and botulinum neurotoxins Q. Rev. Biophys. 28 1995 423 472
5. E.A. Johnson Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins Annu. Rev. Microbiol. 53 1999 551 575
6. D.B. Lacy, W. Tepp, A.C. Cohen, B.R. DasGupta, and R.C. Stevens Crystal structure of botulinum neurotoxin type A and implications for toxicity Nat. Struct. Biol. 5 1998 898 902
7. B. Segelke, M. Knapp, S. Kadkhodayan, R. Balhorn, and B. Rupp Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: evidence for noncanonical zinc protease activity Proc. Natl. Acad. Sci. USA 101 2004 6888 6893
8. M.A. Breidenbach, and A.T. Brunger Substrate recognition strategy for botulinum neurotoxin serotype A Nature 432 2004 925 929
9. A.G. Zdanovsky, N.V. Karassina, D. Simpson, and M.V. Zdanovskaia Peptide phage display library as source for inhibitors of clostridial neurotoxins J. Protein Chem. 20 2001 73 80
10. R.W. Roberts, and J.W. Szostak RNA-peptide fusions for the in vitro selection of peptides and proteins Proc. Natl. Acad. Sci. USA 94 1997 12297 12302
11. D.S. Wilson, A.D. Keefe, and J.W. Szostak The use of mRNA display to select high-affinity protein-binding peptides Proc. Natl. Acad. Sci. USA 98 2001 3750 3755
12. T.T. Takahashi, R.J. Austin, and R.W. Roberts mRNA display: ligand discovery, interaction analysis and beyond Trends Biochem. Sci. 28 2003 159 165
13. R.R. Gerona, E.C. Larsen, J.A. Kowalchyk, and T.F. Martin The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes J. Biol. Chem. 275 2000 6328 6336
14. D.M. Hoover, and J. Lubkowski DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis Nucleic Acids Res. 30 2002 e43
15. W.P. Stemmer, A. Crameri, K.D. Ha, T.M. Brennan, and H.L. Heyneker Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides Gene 164 1995 49 53
16. T. Wang, E. Evdokimov, K. Yiadom, Z. Yan, P.B. Chock, and D.C. Yang Biotin-ubiquitin tagging of mammalian proteins in Escherichia coli Protein Expr. Purif. 30 2003 140 149
17. R. Liu, J.E. Barrick, J.W. Szostak, and R.W. Roberts Optimized synthesis of RNA-protein fusions for in vitro protein selection Methods Enzymol. 318 2000 268 293
18. J.R. Sampson, and O.C. Uhlenbeck Biochemical and physical characterization of an unmodified yeast phenylalanine transfer RNA transcribed in vitro Proc. Natl. Acad. Sci. USA 85 1988 1033 1037
19. J.E. Barrick, T.T. Takahashi, A. Balakin, and R.W. Roberts Selection of RNA-binding peptides using mRNA-peptide fusions Methods 23 2001 287 293
20. D.R. Gallie, D.E. Sleat, J.W. Watts, P.C. Turner, and T.M. Wilson Mutational analysis of the tobacco mosaic virus 5′-leader for altered ability to enhance translation Nucleic Acids Res. 16 1988 883 893
21. J.J. Schmidt, and R.G. Stafford A high-affinity competitive inhibitor of type A botulinum neurotoxin protease activity FEBS Lett. 532 2002 423 426
22. S. Kadkhodayan, M.S. Knapp, J.J. Schmidt, S.E. Fabes, B. Rupp, and R. Balhorn Cloning, expression, and one-step purification of the minimal essential domain of the light chain of botulinum neurotoxin type A Protein Expr. Purif. 19 2000 125 130
23. M.R. Baldwin, M. Bradshaw, E.A. Johnson, and J.T. Barbieri The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability Protein Expr. Purif. 37 2004 187 195
24. J.E. Keller, J.L. Nowakowski, M.G. Filbert, and M. Adler Rapid microplate assay for monitoring botulinum neurotoxin B catalytic activity J. Appl. Toxicol. 19 Suppl. 1 1999 S13 S17
25. B. Hallis, B.A. James, and C.C. Shone Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities J. Clin. Microbiol. 34 1996 1934 1938
26. O. Rossetto, G. Schiavo, C. Montecucco, B. Poulain, F. Deloye, L. Lozzi, and C.C. Shone SNARE motif and neurotoxins Nature 372 1994 415 416
27. V.V. Vaidyanathan, K. Yoshino, M. Jahnz, C. Dorries, S. Bade, S. Nauenburg, H. Niemann, and T. Binz Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage J. Neurochem. 72 1999 327 337
28. G.J. Doellgast, M.X. Triscott, G.A. Beard, and J.D. Bottoms Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes J. Clin. Microbiol. 32 1994 851 853
29. H.Y. Chao, Y.C. Wang, S.S. Tang, and H.W. Liu A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A Toxicon 43 2004 27 34
30. J. Temsamani, and P. Vidal The use of cell-penetrating peptides for drug delivery Drug Discov. Today 9 2004 1012 1019
31. M. Hallbrink, J. Oehlke, G. Papsdorf, and M. Bienert Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration Biochim. Biophys. Acta 1667 2004 222 228